Literature DB >> 25724993

Rates of Complications After Newborn Circumcision in a Well-Baby Nursery, Special Care Nursery, and Neonatal Intensive Care Unit.

Mythili Srinivasan1, Corrine Hamvas2, Douglas Coplen2.   

Abstract

OBJECTIVE/
METHOD: To determine rates of complications after newborn circumcision by performing a retrospective chart review of patients circumcised at a well-baby nursery, neonatal intensive care units (NICU), and special care nursery (SCN) from 2007 to 2012. RESULT: A total of 5129 babies (73%) were circumcised at the well-baby nursery and 1909 babies (27%) at the NICU and SCN. Forty-seven patients (0.67%, 95% CI 0.49% to 0.89%) had circumcision-related complications: 5 (0.07%) patients with acute and 42 (0.6%) with late complications. Babies in the NICU/SCN had increased odds of complication (OR 4.00, 95% CI 2.23 to 7.19) compared with those in well-baby nursery. There were increased odds of complications in babies with Caucasian ethnicity (OR 2.60, 95% CI 1.48 to 4.89) compared with African American babies and in babies with private insurance (OR 4.0, 95% CI 2.1 to 7.5) compared with nonprivate insurance.
CONCLUSIONS: The rates of complications after newborn circumcisions were low. Babies in the NICU/SCN had increased odds of complication.
© The Author(s) 2015.

Entities:  

Keywords:  phimosis; redundant foreskin; revision circumcision

Mesh:

Year:  2015        PMID: 25724993     DOI: 10.1177/0009922815573932

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

Review 1.  Systematic review of complications arising from male circumcision.

Authors:  Stanca Iris Iacob; Richard S Feinn; Lauren Sardi
Journal:  BJUI Compass       Date:  2021-11-11

2.  Evidence-based circumcision policy for Australia.

Authors:  Brian J Morris; Athos Katelaris; Norman J Blumenthal; Mohamed Hajoona; Adrian C Sheen; Leslie Schrieber; Eugenie R Lumbers; Alex D Wodak; Phillip Katelaris
Journal:  J Mens Health       Date:  2022-05-30       Impact factor: 0.789

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.